Read + Share
Weng D, Chen J, Lin C. Absolute risk stratification of HCC after HCV cure in MASLD: do advanced
steatosis and dysglycaemia add beyond liver stiffness? Gut 2026 Mar 2:gutjnl-2026-338294. doi: 10.1136/gutjnl-2026-338294.
PMID: 41771700
|
 |
|
Weng D, Chen J, Lin C. Absolute risk stratification of HCC after HCV cure in MASLD: do advanced
steatosis and dysglycaemia add beyond liver stiffness? Gut 2026 Mar 2:gutjnl-2026-338294. doi: 10.1136/gutjnl-2026-338294.
PMID: 41771700
|
|
|
|